Invest
Myovant Sciences provides an update on a supplemental new drug
Myovant Sciences (NYSE: MYOV) and Pfizer (NYSE: PFE) announced an update for an sNDA for MYFEMBREE, which is designed to manage severe to moderate pain linked to endometriosis.
Why you should accumulate Shopify now as RSI declines to an oversold region
Shopify Inc. (NYSE:SHOP) announced a stock split that is subject to shareholders’ approval. A stock split should, theoretically, not cause any notable price movements. It
DocuSign has returned 42% in a month. Technical indicators show another 50% surge
Since touching a low of $72 on March 15, DocuSign Inc. (NASDAQ:DOCU) has been going higher. At the bottom, the stock was massively oversold, with
Raytheon and Lockheed RSI show varying levels of investor accumulation. Which arm maker is better?
Raytheon Technologies Corp. (NYSE:RTX) and Lockheed Martin (NYSE:LMT) have continued to gain as defense spending increases. Raytheon is trading at a valuation of $103.37. Yesterday,
Deutsche Bank: Honeywell could be a $230 stock
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Zoom Video Communications to focus on M&A in fiscal 2023
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and
Peloton stock price forecast as the firm changes strategy
The Peloton (NASDAQ: PTON) stock price has been in a relentless sell-off in the past few months as concerns about the company’s future remain. The
Elon Musk offers to buy Twitter for $43 billion: here’s where to buy Twitter stock
Twitter stock has been going through a turbulent period after Elon Musk decided to buy a majority share in the company; something that even prompted
Market update: Nasdaq declines 2% as stocks hit 4-week low
Nasdaq fell 2.2% on Thursday as US stocks closed lower ahead of the holiday weekend. The declines across Wall Street came on the day several
Nike stock price forecast: UBS sees a 30% upside
Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling each user to make educated decisions with their money and